ICDM 2025

Special interest session (K) Artificial intelligence, the humanities, and medicine
(인공지능, 인문학, 그리고 의료) Chair(s): Kyoil Suh, Sin Gon Kim
Thursday 25 September, 16:30~17:50
Room 1
(Vista 1+2, B2F)

The emergence of artificial intelligence (AI) marks a pivotal turning point in human civilization. As highlighted by the recipients of the 2024 Nobel Prizes in Physics and Chemistry, the pace of AI advancement is surpassing expectations across scientific disciplines. But should we greet this progress with unreserved optimism? In this special session, two of Korea’s most esteemed scholars will offer deep reflections on the AI era from a humanities-based perspective. Their lectures will examine how humanity is preparing for the societal transformations driven by AI and explore the evolving identity and purpose of medical professionals in this new landscape. Following the presentations, a 20-minute panel discussion with AI experts will further explore the future of human–AI coexistence and the shifting roles of healthcare professionals. Simultaneous AI-powered interpretation will be available in 37 languages.
인공지능(AI)의 급속한 발전은 인류 문명의 새로운 전환점을 예고하고 있다. 2024년 노벨 물리학상과 화학상 수상이 보여주듯, AI 기술의 진보는 우리의 예상을 뛰어넘는 속도로 진행되고 있다. 그러나 이러한 발전을 마냥 낙관적으로만 바라보아도 될까? 이번 특별 세션에서는 대한민국을 대표하는 두 석학을 모시고, 인공지능 시대를 인문학적 관점에서 깊이 있게 성찰하고자 한다. 인류가 어떤 준비를 해야 하는지, 그리고 변화하는 시대 속에서 의료전문가는 어떤 역할을 수행하게 될지를 고찰하는 시간이 될 것이다. 각 30분 강연에 이어, AI 전문가 패널과 함께 20분간의 토론이 진행된다. 또한, 인공지능 기반 동시통역 시스템을 통해 총 37개국 언어로 실시간 통역이 제공될 예정이다.

SIS1-L1 Sang Wook YiHanyang University, Korea: Reconsidering humanity in the age of AI (인공지능 시대, 인간을 다시 생각한다)

SIS1-L2 Woo-taek JeonYonsei University, Department of Medical Education, Korea: Essential questions doctors must answer in the face of AI (의사들이 인공지능(AI)을 마주하며 반드시 답해야 할 핵심 질문들)

SIS1-P1 AI PanelKDA, Korea: Panel discussion

Hot publication debate session COMBINE 1, ACHIEVE 1 and CONFIDENCE trials Chair(s): Jeong Hyun Park, Gwanpyo Koh
Saturday 27 September, 08:40~10:00
Room 1
(Vista 1+2, B2F)

This session reviews key research papers published in the field of diabetes and metabolic diseases over the past year. The selected papers include the ACHIEVE1 trial, which examines the glucose lowering efficacy of orforglipron in type 2 diabetes patients, a phase 3a trial on the efficacy of once‑weekly IcoSema (COMBINE1 trial), and the CONFIDENCE trial, which examined the effects of finerenone plus empagliflozin on albuminuria in patients with both chronic kidney disease and type 2 diabetes. The session aims to critically analyze the results, significance, and limitations of each study, providing a comprehensive overview of the latest research trends in diabetes and metabolic diseases.

SIS2-L1 Hyun Ah KimVeterans Health Service Medical Center, Korea: Orforglipron, an oral small-molecule GLP-1 receptor agonist, in early type 2 diabetes: a review of the ACHIEVE-1 trial

SIS2-L2 Young Min ChoSeoul National University, Korea: Discussion on ACHIEVE-1 study

SIS2-L3 Yu Ji KimJeonbuk National University, Korea: Once-weekly IcoSema versus once-weekly insulin icodec in type 2 diabetes management (COMBINE 1): a randomized, open-label, phase 3a trial

SIS2-L4 Linong JiPeking University, China: All about COMBINE 1 trial

SIS2-L5 Inha JungKorea University , Korea: Finerenone with empagliflozin in chronic kidney disease and type 2 diabetes

SIS2-L6 Jennifer B. GreenDuke University, USA: Clinical importance of the CONFIDENCE trial

Year in review and perspective Year in review and perspective Chair(s): Soon Jib Yoo, Chul-Hee Kim
Saturday 27 September, 16:00~17:00
Room 1
(Vista 1+2, B2F)

This session highlights important research findings in diabetes and its management over the past year, with insights from leading experts. Speakers will provide a critical overview of recent developments and offer perspectives on key directions for future research.

SIS4-L1 Jae Hyeon KimSungkyunkwan University, Korea: Technology-driven monitoring and management

SIS4-L2 Shivani MisraImperial College London, UK: Precision medicine and subclassification of diabetes

SIS4-L3 Soo LimSeoul National University, Korea: Redefining obesity: translational insights and future challenges

The great talk: ask us anything (K) TBD Chair(s): Sin Gon Kim, Junghyun Noh
Saturday 27 September, 13:10~14:30
Room 3
(Walker hall 1, 1F)

The great talk special session has invited esteemed professors who have dedicated more than 30 years of their careers to the field of diabetology. These distinguished professors have played a pivotal role in shaping discipline and have a wealth of knowledge and experience to share. This exclusive event provides a unique opportunity for future generations of diabetologists to learn from the insights and wisdom of these seasoned professionals. Attendees will gain valuable perspectives on successful careers in diabetology and immerse themselves in the remarkable journeys of their esteemed seniors.
The great talk 특별 세션에서는 내분비 인생의 길을 30여년 이상 걸어오신 인생의 선배이자 이 분야를 선도해 오신 교수들을 모시고, 다양한 경험과 의사이자 학자, 그리고 교육자로서 소중한 지혜를 미래 세대에 전수할 수 있는 장을 마련했다. 인생 선배들의 여정에 빠져들어 그분들의 통찰력에서 배우며 내분비학자로서 성공적인 삶을 엿보는 기회가 될 것이다.

SIS3-L1 Kyung Soo KoInje University, Korea: Long journey to the patients, still going
(내분비내과 교수의 긴 여정)

SIS3-L2 Tae Sun ParkJeonbuk National Univeristy, Korea: My decision to diabetes as a professor
(교수로서 당뇨병에 대한 나의 결정)

Special breakfast symposium (K) Heritage and future hope of KDA Chair(s): , Bong-Soo Cha
Saturday 27 September, 08:00~09:00
Room 6~7
(Grand hall 4~5, B1F)

In 2028, the Korean Diabetes Association (KDA) will celebrate its 60th anniversary. Starting from humble beginnings 57 years ago, the KDA has grown into an organization of 4,000 members thanks to the devoted efforts of its pioneers and senior members. As it reaches this 60-year milestone, the KDA is preparing to become a world leader in diabetes research and care with global standards. This session will look back at the KDA's history, cast a vision for its future, and allow members to solidify their own visions through the experience and wisdom of their seniors.
2028년, 대한당뇨병학회(KDA)는 창립 60주년을 맞이합니다. 57년 전, 불모지에서 시작된 KDA는 선각자들과 선배 회원들의 헌신적인 노력으로 현재 4,000명 규모의 학회로 성장했습니다. 60주년을 기점으로, KDA는 당뇨병 연구 및 치료 분야에서 글로벌 표준을 제시하는 리더로 도약할 준비를 하고 있습니다. 본 세션에서는 KDA의 역사를 되짚어보고 미래를 조망하며, 선배들의 경험과 지혜를 통해 후학들의 비전을 다지는 자리가 될 것입니다.

SIS5-L1 Hyung Joon YooCM Hospital, Korea: KDA, our heritage, our pride
(KDA, 우리 유산, 우리 자랑)

SIS5-L2 Sin Gon KimKorea University, Korea: From legacy to innovation: KDA’s vision for the future of diabetes
(KDA 현재와 미래 비전)

SIS5-P1 Dong Seop ChoiGovernment Complex Gwacheon Clinic, Korea: Panel discussion

SIS5-P2: Panel discussion

SIS5-P3 Kyu Jeung AhnKyung Hee University, Korea: Panel discussion

SIS5-P4 Sungrae KimThe Catholic University of Korea, Korea: Panel discussion

Young diabetologist boot camp (K) Real talk for future diabetologists and medical students Chair(s): Byung Joon Kim, Nam Hoon Kim
Saturday 27 September, 14:40~16:00
Room 6~7
(Grand hall 4~5, B1F)

SIS6-L1 Jae-Han JeonKyungpook National University, Korea: Principles of glucose regulation: from physiology and pathology
(혈당 조절의 원리와 당뇨병 이환의 병태생리)

SIS6-L2 Tae Jung OhSeoul National University, Korea: Incretin-based therapies: from diabetes to obesity management (당뇨병 치료에서 비만 치료까지: 인크레틴의 역할)

SIS6-L3 Sin Gon KimKorea University, Korea: An AI Odyssey: preparing for the future of diabetes care (AI 오디세이: 당뇨병 치료의 미래와 우리의 준비)

구분		사전등록 (~2025년 8월 20일까지)		현장등록 (2025년 9월 25일 ~ 27일)
구분		KDA회원	비회원	KDA회원	비회원
25~27일 등록	전문의(개원의, 교수, 봉직의, 전임의 포함)	KRW 280,000	KRW 350,000	KRW 370,000	KRW 450,000
25~27일 등록	전공의, 간호사, 영양사, 사회복지사, 약사, 연구원, 운동처방사, 관련분야 교수 및 기타 (군의관 및 공중보건의 포함)	KRW 180,000	KRW 230,000	KRW 250,000	KRW 270,000
One-day 등록	전문의(개원의, 교수, 봉직의, 전임의 포함)	KRW 170,000	KRW 210,000	KRW 220,000	KRW 270,000
One-day 등록	전공의, 간호사, 영양사, 사회복지사, 약사, 연구원, 운동처방사, 관련분야 교수 및 기타 (군의관 및 공중보건의 포함)	KRW 110,000	KRW 140,000	KRW 150,000	KRW 160,000
저녁 식사	전체	KRW 55,000

Program details

평점안내 (For Korean)